Clinical benefits of TNF‐α inhibitors in Chinese adult patients with NLRP3‐associated autoinflammatory disease-Reference-Cited by-同舟云学术

Clinical benefits of TNF‐α inhibitors in Chinese adult patients with NLRP3‐associated autoinflammatory disease

Published:2021-06-12 Issue:4 Volume:290 Page:878-885
ISSN:0954-6820
Container-title:Journal of Internal Medicine
language:en
Short-container-title:J Intern Med

Author:

Wu N.¹^ORCID,Wu D.¹,Zhao M.¹^ORCID,Miao J.¹,Yu W.²,Wang Y.³,Shen M.¹

Affiliation:

1. From the Department of Rheumatology and Clinical Immunology State Key Laboratory of Complex Severe and Rare Diseases Peking Union Medical College Hospital Chinese Academy of Medical Sciences & Peking Union Medical College National Clinical Research Center for Dermatologic and Immunologic Diseases (NCRC‐DID) Key Laboratory of Rheumatology and Clinical Immunology Ministry of Education BeijingChina

2. Department of Ophthalmology Peking Union Medical College Hospital Chinese Academy of Medical Sciences & Peking Union Medical College Beijing China

3. Department of Otolaryngological Peking Union Medical College Hospital Chinese Academy of Medical Sciences & Peking Union Medical College Beijing China

Funder

Natural Science Foundation of Beijing Municipality

National Key Research and Development Program of China

Publisher

Wiley

Subject

Internal Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/joim.13334

Reference29 articles.

1. An International registry on Autoinflammatory diseases: the Eurofever experience

2. CAPS — pathogenesis, presentation and treatment of an autoinflammatory disease